LONDON and PHOENIX, March 23, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC Pink: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce
Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC PINK: ACUT), a life sciences company dedicated to improving outcomes